Marine Polymer Technologies News

News Releases for Marine Polymer Technologies, Inc.

Marine Polymer Technologies, Inc. is dedicated to improving the well-being of patients, providing effective solutions to doctors and nurses, and to the betterment of our community and employees. Learn more about MPT's latest news updates by clicking on the links below.

  • April 8, 2013 Talymed® Approved for Medicare Pass-Through Status

    Marine Polymer Technologies, Inc.(MPT), a leading manufacturer and marketer of advanced wound-care products, is pleased to announce that theCenters for Medicare Medicaid Services(CMS) has awarded Talymed®pass-through status through the Ambulatory Payment Classification (APC) 1449 for payments under the Hospital Outpatient Prospective Payment System (OPPS). This code will facilitate reimbursement for the application ofTalymed®when used for... Read more

  • July 9, 2012 BioMedEcon Reports Nearly 20-Fold Difference in Cost Efficacy of Skin Substitutes to Treat Venous Leg Ulcers

    According to a landmark study published this month in theJournal of Managed Care Pharmacyand presented at the4thBiennial Conference of the American Society of Health Economists held at the University of Minnesota, the most expensive skin substitutes (also known as “advanced wound care matrices”) for the treatment of venous leg ulcers (VLUs) may not provide the greatest clinical or cost efficacy. A copy of the published article, entitled... Read more

  • March 16, 2012 Federal Circuit Affirms En Banc Over $34.2 Million Judgment For Marine Polymer And Permanent Injunction Against HemCon

    On March 15, 2012, the Court of Appeals for the Federal Circuit affirmed, in an en banc decision,all aspects of the 2010 judgment of the New Hampshire District Court in favor of Marine Polymer Technologies, Inc.following a ten-day jury trial against competitor HemCon, Inc. This judgment includes a damages verdict in excess of $29.4 million, additional post-trial damages for infringing sales in 2010, and prejudgment interest, for a total of over... Read more

  • June 22, 2011 Marine Polymer Technologies Announces Positive Results of Talymed® Clinical Trial Published in the Journal of the American Academy of Dermatology

    Marine Polymer Technologies, Inc. today announced that positive clinical trial results of Talymed®, an advanced bio-active wound-healing technology, for the treatment of patients with hard-to-heal venous leg ulcers (VLUs) were published in theJournal of the American Academy Dermatology.The study compared the proportion of patients who achieved complete wound healing at 20 weeks using Talymed plus standard care versus those who received standard... Read more

  • September 22, 2010 Marine Polymer Technologies, Inc. Awarded Permanent Injunction in Patent Infringement Lawsuit Against Competitor, HemCon, Inc.

    Medical device company Marine Polymer Technologies, Inc. announced that on September 16, 2010, the United States District Court for the District of New Hampshire entered an Order permanently enjoining HemCon, Inc. from infringing Marine Polymer’s United States Patent No. 6,864,245. The Order is the latest ruling in a patent infringement lawsuit, which was filed in March 2006 by Marine Polymer, concerning biocompatible polymers known in the... Read more